2017
DOI: 10.21037/atm.2017.07.13
|View full text |Cite
|
Sign up to set email alerts
|

Target-specific deep brain stimulation of the ventral capsule/ventral striatum for the treatment of neuropsychiatric disease

Abstract: Deep brain stimulation (DBS) is a well-established therapy for Parkinson's disease and other movement disorders. An accumulating body of evidence supports the extension of DBS application for the treatment of refractory psychiatric disorders. The ventral capsule/ventral striatum (VC/VS) is the most common anatomical target for obsessive-compulsive disorder (OCD), addiction, and depression. However, no specific electrode is available for the clinical targeting of these areas for DBS. According to the anatomical… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 34 publications
0
4
0
Order By: Relevance
“…The currently available electrode models contain four contacts of 1.5 mm in length and are separated from one another by 0.5, 1.0, or 1.5 mm intervals. SceneRay has also designed an electrode to specifically to target the nucleus accumbens and anterior limb of the internal capsule [ 58 ]. The lead has four contacts of 3.0 mm in length; the two ventral-most contacts are separated by 2 mm, and the more dorsal contacts are separated by 4 mm.…”
Section: Update On Devicesmentioning
confidence: 99%
“…The currently available electrode models contain four contacts of 1.5 mm in length and are separated from one another by 0.5, 1.0, or 1.5 mm intervals. SceneRay has also designed an electrode to specifically to target the nucleus accumbens and anterior limb of the internal capsule [ 58 ]. The lead has four contacts of 3.0 mm in length; the two ventral-most contacts are separated by 2 mm, and the more dorsal contacts are separated by 4 mm.…”
Section: Update On Devicesmentioning
confidence: 99%
“…In a previous report, [ 16 ] a 3387 lead (Medtronic, 1.5 mm contacts) was used and a very high stimulation (8.0 V, 150 µs, 200 Hz) was needed to achieve any clinical effect. Here, we selected an electrode with four longer lead contacts (3 mm), which may result in a much larger stimulation area and allow stimulation at increasing intensity and density [ 22 ]. In addition, our contacts on the SCP were near the midbrain, and electrodes were positioned across both the SCP and DN to allow optimal target programming.…”
Section: Discussionmentioning
confidence: 99%
“…DBS was proposed as a reversible approach that would achieve the benefits of a lesion. This target, the Ventral Capsule/Ventral Striatum (VC/VS), is part of the cortico-striato-thalamo-cortical (CSTC) loop circuitry that is hypothesized to be the basis of OCD symptoms ( Zhang et al 2017 , Dougherty et al 2018 ). An additional target was identified through DBS research in PD, where OCD symptoms were decreased for an individual when given subthalamic nucleus (STN) stimulation ( Fontaine et al 2004 ).…”
Section: Overview Of Dbs For Ocdmentioning
confidence: 99%